Search Results - "FALLER, A"

The antioxidant capacity and polyphenol content of organic and conventional retail vegetables after domestic cooking by Faller, A.L.K., Fialho, E.

“…Vegetable consumption is associated with health benefits. Organic foods are thought to have higher contents of antioxidant substances. The objective of this…”
Get full text

Polyphenol content and antioxidant capacity in organic and conventional plant foods by Faller, A.L.K., Fialho, E.

“…Fruit and vegetable intake is associated with lower risk of chronic diseases as a result of consumption of antioxidant substances. Organic foods are thought to…”
Get full text

True Strength of Ceramic Fiber Bundles: Experiments and Simulations by Neckel, Leandro, Faller, Cristian A, Babič, Matej, Montedo, Oscar R K, Bergmann, Carlos P, Janssen, Rolf

“…A study on the strength of ceramic fiber bundles based on experimental and computational procedures is presented. Tests were performed on single filaments and…”
Get full text

Incidence and risk factors of venous thromboembolism: Peculiarities in psychiatric institutions by Gaertner, S., Piémont, A., Faller, A., Bertschy, G., Hallouche, N., Mirea, C., Le Ray, I., Cordeanu, E.-M., Stephan, D.

“…The objectives of this study were to assess the incidence and risk factors for venous thromboembolism (VTE) in a population of patients hospitalized in a…”
Get full text

Platelet rich plasma and growth factors cocktails for diabetic foot ulcers treatment: State of art developments and future prospects by Gonchar, I.V., Lipunov, A.R., Afanasov, I.M., Larina, V., Faller, A.P., Kibardin, A.V.

“…Current advances in diabetic foot ulcers (DFU) treatment are discussed. Normal and pathological wound healing process are observed and the role of growth…”
Get full text

From the market to the plate: Fate of bioactive compounds during the production of feijoada meal and the impact on antioxidant capacity by Faller, A.L.K., Fialho, E.

“…Consumption of plant foods are known to reduce the risk of developing non-communicable diseases. However, many foods are not consumed in their natural state…”
Get full text

Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy by Faller, Bryan A, Burtness, Barbara

“…Overviews the use of epidermal growth factor receptor (EGFR) inhibitors in the treatment of pancreatic adenocarcinoma, with particular reference to overall…”
Get full text

Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC by Hensing, Thomas A., Wang, Xiaofei, Stinchcombe, Thomas E., Gao, Junheng, Knopp, Michael V., Watson, Mark, Dudek, Arkadiusz Z., Graziano, Stephen L., Patel, Jyoti D., Faller, Bryan A., Dragnev, Konstantin H., Kozono, David, Vokes, Everett E.

“…The sequence of chemotherapy and pembrolizumab may affect antitumor immune response and efficacy of immunotherapy. This multicenter, randomized, phase 2 trial…”
Get full text

Safety and Efficacy of Vinorelbine in the Treatment of Non-Small Cell Lung Cancer by Faller, Bryan A., Pandit, Trailokya N.

“…Lung cancer remains the most frequently diagnosed cancer in the United States, excluding non-melanoma skin cancer. Non-small cell lung cancer (NSCLC)…”
Get full text

E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group by Connolly, Roisin M, Zhao, Fengmin, Miller, Kathy D, Lee, Min-Jung, Piekarz, Richard L, Smith, Karen L, Brown-Glaberman, Ursa A, Winn, Jennifer S, Faller, Bryan A, Onitilo, Adedayo A, Burkard, Mark E, Budd, George T, Levine, Ellis G, Royce, Melanie E, Kaufman, Peter A, Thomas, Alexandra, Trepel, Jane B, Wolff, Antonio C, Sparano, Joseph A

“…Endocrine therapy resistance in advanced breast cancer remains a significant clinical problem that may be overcome with the use of histone deacetylase…”
Get full text

Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial by Algazi, Alain P., Othus, Megan, Daud, Adil I., Lo, Roger S., Mehnert, Janice M., Truong, Thach-Giao, Conry, Robert, Kendra, Kari, Doolittle, Gary C., Clark, Joseph I., Messino, Michael J., Moore, Dennis F., Lao, Christopher, Faller, Bryan A., Govindarajan, Rangaswamy, Harker-Murray, Amy, Dreisbach, Luke, Moon, James, Grossmann, Kenneth F., Ribas, Antoni

“…Preclinical modeling suggests that intermittent BRAF inhibitor therapy may delay acquired resistance when blocking oncogenic BRAF V600 in melanoma 1 , 2 . We…”
Get full text

Difficulties in the diagnosis of diarrhea-associated hemolytic uremic syndrome in adults by V A Malov, V V Maleev, N L Kozlovskaya, N A Tsvetkova, S V Smetanina, A N Gorobchenko, V V Serova, V B Chentsov, A G Volkov, A P Faller

“…Hemolytic uremic syndrome (HUS) is a rare, but menacing condition registered mainly in children. The paper gives a detailed description and analysis of a…”
Get full text

Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208) by Hochster, Howard S, Catalano, Paul, Weitz, Michelle, Mitchell, Edith P, Cohen, Deirdre, O’Dwyer, Peter J, Faller, Bryan A, Kortmansky, Jeremy S, O’Hara, Mark H, Kricher, Sheetal M, Lacy, Jill, Lenz, Heinz-Josef, Verma, Udit, Benson, Al B

“…Early studies showed promise of combined anti-epidermal growth factor receptor (EGFR) plus anti-vascular endothelial growth factor (VEGF) antibodies for…”
Get full text

Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial by Rahma, Osama E, Yothers, Greg, Hong, Theodore S, Russell, Marcia M, You, Y Nancy, Parker, William, Jacobs, Samuel A, Colangelo, Linda H, Lucas, Peter C, Gollub, Marc J, Hall, William A, Kachnic, Lisa A, Vijayvergia, Namrata, O'Rourke, Mark A, Faller, Bryan A, Valicenti, Richard K, Schefter, Tracey E, George, Sagila, Kainthla, Radhika, Stella, Philip J, Sigurdson, Elin, Wolmark, Norman, George, Thomas J

“…Total neoadjuvant therapy (TNT) is often used to downstage locally advanced rectal cancer (LARC) and decrease locoregional relapse; however, more than…”
Get more information

Effect of LZSA glass-ceramic addition on the erosive wear of pressureless sintered alumina by Montedo, Oscar Rubem K., Milak, Pâmela C., Faller, Cristian A., Bergmann, Carlos Pérez, Noni Jr, Agenor De

“…Abstract This study aims to evaluate the influence of the 11.6Li2O-16.8ZrO2-68.2SiO2-3.4Al2O3 (mol%) glass-ceramic addition (LZSA, 7 to 21 vol%) on the erosive…”
Get full text

A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome by Marx, David, Dupuis, Arnaud, Eckly, Anita, Molitor, Anne, Olagne, Jérôme, Touchard, Guy, Kaaki, Sihem, Ory, Cécile, Faller, Anne-Laure, Gérard, Bénédicte, Cotter, Melanie, Westerberg, Lisa, Keszei, Marton, Moulin, Bruno, Gachet, Christian, Caillard, Sophie, Bahram, Seiamak, Carapito, Raphaël

“…While loss-of-function variants in the WAS gene are associated with Wiskott-Aldrich syndrome and lead to microthrombocytopenia, gain-of-function variants of…”
Get full text

Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma by Hall, William A, Li, Jiahe, You, Y Nancy, Gollub, Marc J, Grajo, Joseph R, Rosen, Mark, dePrisco, Greg, Yothers, Greg, Dorth, Jennifer A, Rahma, Osama E, Russell, Marcia M, Gross, Howard M, Jacobs, Samuel A, Faller, Bryan A, George, Sagila, Al Baghdadi, Tareq, Haddock, Michael G, Valicenti, Richard, Hong, Theodore S, George, Thomas J

“…Total neoadjuvant therapy (TNT) is a newly established standard treatment for rectal adenocarcinoma. Current methods to communicate magnitudes of regression…”
Get full text

A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152) by Bradbury, Angela R., Lee, Ju‐Whei, Gaieski, Jill Bennett, Li, Shuli, Gareen, Ilana F., Flaherty, Keith T., Herman, Benjamin A., Domchek, Susan M., DeMichele, Angela M., Maxwell, Kara N., Onitilo, Adedayo A., Virani, Shamsuddin, Park, SuJung, Faller, Bryan A., Grant, Stefan C., Ramaekers, Ryan C., Behrens, Robert J., Nambudiri, Gopakumar S., Carlos, Ruth C., Wagner, Lynne I.

“…Background Enthusiasm for precision oncology may obscure the psychosocial and ethical considerations associated with the implementation of tumor genetic…”
Get full text

External Validation of Risk Factors for Unplanned Hospitalization in Older Adults With Advanced Cancer Receiving Chemotherapy by Mohamed, Mostafa R, Loh, Kah Poh, Mohile, Supriya G, Sohn, Michael, Webb, Tracy, Wells, Megan, Yilmaz, Sule, Tylock, Rachael, Culakova, Eva, Magnuson, Allison, Sun, Can-Lan, Bearden, James, Hopkins, Judith O, Faller, Bryan A, Klepin, Heidi D

“…Older adults (age ≥65 years) receiving chemotherapy are at risk for hospitalization. Predictors of unplanned hospitalization among older adults receiving…”
Get more information

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811) by Argiris, Athanassios, Miao, Jieling, Cristea, Mihaela C., Chen, Allen M., Sands, Jacob M., Decker, Roy H., Gettinger, Scott N., Daly, Megan E., Faller, Bryan A., Albain, Kathy S., Yanagihara, Ronald H., Garland, Linda L., Byers, Lauren A., Wang, Ding, Koczywas, Marianna, Redman, Mary W., Kelly, Karen, Gandara, David R.

“…We conducted a 2-part study to evaluate the incorporation of veliparib, a PARP inhibitor, into chemoradiotherapy (CRT) for stage III non–small-cell lung…”
Get full text